Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
|
US |
|
Fortinet Inc
NASDAQ:FTNT
|
US |
|
A
|
Avenira Ltd
ASX:AEV
|
AU |
|
L
|
LOTVacuum Co Ltd
KOSDAQ:083310
|
KR |
|
A
|
Allegiant Professional Business Services Inc
OTC:APRO
|
US |
|
Eckoh PLC
LSE:ECK
|
UK |
|
American Lithium Corp
XTSX:LI
|
CA |
|
A
|
Amata VN PCL
SET:AMATAV
|
TH |
|
Post Holdings Inc
NYSE:POST
|
US |
Wall Street
Price Targets
RIGL Price Targets Summary
Rigel Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
RIGL
is 52.22 USD
with a low forecast of 38.38 USD and a high forecast of 74.55 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is RIGL's stock price target?
Price Target
52.22
USD
According to Wall Street analysts, the average 1-year price target for
RIGL
is 52.22 USD
with a low forecast of 38.38 USD and a high forecast of 74.55 USD.
What is Rigel Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
7%
For the last 14 years the
compound annual growth rate for
Rigel Pharmaceuticals Inc's revenue is
34%.
The projected
CAGR
for the next 3 years is
7%.
What is Rigel Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
-3%
The
compound annual growth rate
of Rigel Pharmaceuticals Inc's operating income for the next 3 years is
-3%.
What is Rigel Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
-37%
The
compound annual growth rate
of Rigel Pharmaceuticals Inc's net income for the next 3 years is
-37%.
